IPG1094 Phase I Study for China Healthy Participants

Clinical trial NCT07679113 · RECRUITING

Trial details

NCT number: NCT07679113
Sponsor: Nanjing Immunophage Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2026-07-30
Primary completion: 2027-01-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.